183,632 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC bought a new position in Grail, Inc. (NASDAQ:GRAL) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 183,632 shares of the company’s stock, valued at approximately $3,278,000. Commonwealth Equity Services LLC owned 0.55% of Grail as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. PGGM Investments purchased a new position in shares of Grail during the 4th quarter valued at $1,224,000. Erste Asset Management GmbH purchased a new position in Grail during the fourth quarter worth about $120,000. Swiss National Bank purchased a new stake in shares of Grail in the 4th quarter valued at about $973,000. HighTower Advisors LLC bought a new stake in shares of Grail during the 4th quarter valued at about $196,000. Finally, Moors & Cabot Inc. purchased a new position in shares of Grail during the fourth quarter worth about $244,000.

Insiders Place Their Bets

In related news, President Joshua J. Ofman sold 2,109 shares of the stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $65,800.80. Following the completion of the sale, the president now directly owns 559,673 shares in the company, valued at $17,461,797.60. This represents a 0.38 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Robert P. Ragusa sold 7,625 shares of the firm’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.21, for a total value of $237,976.25. Following the transaction, the chief executive officer now owns 828,662 shares in the company, valued at approximately $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 11,550 shares of company stock valued at $360,436.

Grail Price Performance

GRAL opened at $31.20 on Wednesday. The business’s fifty day simple moving average is $33.40 and its 200 day simple moving average is $22.17. Grail, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99.

Grail (NASDAQ:GRAL) last announced its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to analysts’ expectations of $35.33 million. As a group, analysts expect that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Morgan Stanley raised their target price on shares of Grail from $16.00 to $20.00 and gave the company an “equal weight” rating in a research note on Tuesday, March 18th.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.